[1]
Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C, American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The journal of pain. 2009 Feb:10(2):113-30. doi: 10.1016/j.jpain.2008.10.008. Epub
[PubMed PMID: 19187889]
[2]
Hudak ML, Tan RC, COMMITTEE ON DRUGS, COMMITTEE ON FETUS AND NEWBORN, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 2012 Feb:129(2):e540-60. doi: 10.1542/peds.2011-3212. Epub 2012 Jan 30
[PubMed PMID: 22291123]
[3]
Toce MS, Chai PR, Burns MM, Boyer EW. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2018 Dec:14(4):306-322. doi: 10.1007/s13181-018-0685-1. Epub 2018 Oct 30
[PubMed PMID: 30377951]
[4]
Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. Journal of pain and symptom management. 2009 Apr:37(4):632-41. doi: 10.1016/j.jpainsymman.2007.12.024. Epub
[PubMed PMID: 19345298]
[5]
Anghelescu DL, Faughnan LG, Hankins GM, Ward DA, Oakes LL. Methadone use in children and young adults at a cancer center: a retrospective study. Journal of opioid management. 2011 Sep-Oct:7(5):353-61
[PubMed PMID: 22165034]
Level 2 (mid-level) evidence
[6]
Mulder DJ, Sherlock ME, Lysecki DL. NMDA-receptor Antagonism in Pediatric Pancreatitis: Use of Ketamine and Methadone in a Teenager With Refractory Pain. Journal of pediatric gastroenterology and nutrition. 2018 May:66(5):e134-e136. doi: 10.1097/MPG.0000000000001907. Epub
[PubMed PMID: 29394214]
[7]
Salsitz E, Wiegand T. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon". Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2016 Mar:12(1):58-63. doi: 10.1007/s13181-015-0517-5. Epub
[PubMed PMID: 26567033]
[8]
Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, Marro P, Oliveira EL, Harvey-Wilkes K, Czynski A, Engelhardt B, D'Apolito K, Bogen D, Lester B. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. JAMA pediatrics. 2018 Aug 1:172(8):741-748. doi: 10.1001/jamapediatrics.2018.1307. Epub
[PubMed PMID: 29913015]
Level 1 (high-level) evidence
[9]
Staszewski CL, Garretto D, Garry ET, Ly V, Davis JA, Herrera KM. Comparison of buprenorphine and methadone in the management of maternal opioid use disorder in full term pregnancies. Journal of perinatal medicine. 2020 Sep 25:48(7):677-680. doi: 10.1515/jpm-2020-0106. Epub
[PubMed PMID: 32681781]
[10]
Fredheim OM, Moksnes K, Borchgrevink PC, Kaasa S, Dale O. Clinical pharmacology of methadone for pain. Acta anaesthesiologica Scandinavica. 2008 Aug:52(7):879-89. doi: 10.1111/j.1399-6576.2008.01597.x. Epub 2008 Mar 7
[PubMed PMID: 18331375]
[11]
Walwyn WM, Miotto KA, Evans CJ. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug and alcohol dependence. 2010 May 1:108(3):156-65. doi: 10.1016/j.drugalcdep.2010.01.001. Epub 2010 Feb 25
[PubMed PMID: 20188495]
[12]
Teixeira MJ, Okada M, Moscoso AS, Puerta MY, Yeng LT, Galhardoni R, Tengan S, Andrade DC. Methadone in post-herpetic neuralgia: A pilot proof-of-concept study. Clinics (Sao Paulo, Brazil). 2013 Jul:68(7):1057-60. doi: 10.6061/clinics/2013(07)25. Epub
[PubMed PMID: 23917673]
Level 3 (low-level) evidence
[13]
Kreek MJ, Reed B, Butelman ER. Current status of opioid addiction treatment and related preclinical research. Science advances. 2019 Oct:5(10):eaax9140. doi: 10.1126/sciadv.aax9140. Epub 2019 Oct 2
[PubMed PMID: 31616793]
Level 3 (low-level) evidence
[14]
Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain - an overview of Cochrane reviews. The Cochrane database of systematic reviews. 2017 Jul 6:7(7):CD012592. doi: 10.1002/14651858.CD012592.pub2. Epub 2017 Jul 6
[PubMed PMID: 28683172]
Level 3 (low-level) evidence
[15]
Toombs JD, Kral LA. Methadone treatment for pain states. American family physician. 2005 Apr 1:71(7):1353-8
[PubMed PMID: 15832538]
[16]
Klaman SL, Isaacs K, Leopold A, Perpich J, Hayashi S, Vender J, Campopiano M, Jones HE. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance. Journal of addiction medicine. 2017 May/Jun:11(3):178-190. doi: 10.1097/ADM.0000000000000308. Epub
[PubMed PMID: 28406856]
[17]
Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Annals of internal medicine. 2009 Mar 17:150(6):387-95
[PubMed PMID: 19153406]
[18]
Moryl N, Pope J, Obbens E. Hypoglycemia during rapid methadone dose escalation. Journal of opioid management. 2013 Jan-Feb:9(1):29-34. doi: 10.5055/jom.2013.0144. Epub
[PubMed PMID: 23709301]
[19]
Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug and alcohol review. 2011 May:30(3):300-5. doi: 10.1111/j.1465-3362.2010.00271.x. Epub
[PubMed PMID: 21545561]
[20]
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19:315(15):1624-45. doi: 10.1001/jama.2016.1464. Epub
[PubMed PMID: 26977696]
[21]
Vazquez V, Gury C, Laqueille X. [Methadone: from pharmacokinetic profile to clinical pharmacology]. L'Encephale. 2006 Jul-Aug:32(4 Pt 1):478-86
[PubMed PMID: 17099560]
[22]
Ferrari A, Coccia CP, Bertolini A, Sternieri E. Methadone--metabolism, pharmacokinetics and interactions. Pharmacological research. 2004 Dec:50(6):551-9
[PubMed PMID: 15501692]
[23]
Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, Blank S, Pampati V, Abdi S, Grider JS, Kaye AD, Manchikanti KN, Cordner H, Gharibo CG, Harned ME, Albers SL, Atluri S, Aydin SM, Bakshi S, Barkin RL, Benyamin RM, Boswell MV, Buenaventura RM, Calodney AK, Cedeno DL, Datta S, Deer TR, Fellows B, Galan V, Grami V, Hansen H, Helm Ii S, Justiz R, Koyyalagunta D, Malla Y, Navani A, Nouri KH, Pasupuleti R, Sehgal N, Silverman SM, Simopoulos TT, Singh V, Solanki DR, Staats PS, Vallejo R, Wargo BW, Watanabe A, Hirsch JA. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain physician. 2017 Feb:20(2S):S3-S92
[PubMed PMID: 28226332]
[24]
Boon M, van Dorp E, Broens S, Overdyk F. Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events. Annals of palliative medicine. 2020 Mar:9(2):542-557. doi: 10.21037/apm.2019.12.09. Epub 2020 Feb 6
[PubMed PMID: 32036672]